Bremelanotide PT 141 structure
|
Common Name | Bremelanotide PT 141 | ||
---|---|---|---|---|
CAS Number | 189691-06-3 | Molecular Weight | 1025.163 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C50H68N14O10 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Bremelanotide PT 141Bremelanotide (PT-141) is an analogue of α-melanocyte-stimulating hormone (α-MSH). Bremelanotide activates the mPOA and other hypothalamic and limbic regions of the brain involved in sexual behavior. Bremelanotide can be used for researching hypoactive sexual desire disorders[1]. |
Name | Bremelanotide |
---|---|
Synonym | More Synonyms |
Description | Bremelanotide (PT-141) is an analogue of α-melanocyte-stimulating hormone (α-MSH). Bremelanotide activates the mPOA and other hypothalamic and limbic regions of the brain involved in sexual behavior. Bremelanotide can be used for researching hypoactive sexual desire disorders[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C50H68N14O10 |
Molecular Weight | 1025.163 |
Exact Mass | 1024.524292 |
PSA | 376.47000 |
LogP | -1.21 |
Index of Refraction | 1.679 |
PT141 Acetate |
BreMelanotide Acetate |
PT-141 |
Bremelanotide PT 141 |
1,4,7,10,13,18-Hexaazacyclotricosane-23-carboxylic acid, 15-[[(2S)-2-(acetylamino)-1-oxohexyl]amino]-6-[3-[(aminoiminomethyl)amino]propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-9-(phenylmethyl)-, (3S,6S,9R,12S,15S,23S)- |
(3S,6S,9R,12S,15S,23S)-15-[(N-Acetyl-L-norleucyl)amino]-9-benzyl-6-(3-carbamimidamidopropyl)-12-(1H-imidazol-4-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxylic acid |
Brmelanotice |
bremelanotide |